Page 32 - JCTR-10-4

254 Sari et al. | Journal of Clinical and Translational Research 2024; 10(4): 246-255
Desai AS, et al. Type 2 Diabetes Mellitus and Heart [13] Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, et al.
Failure: A Scientific Statement from the American Heart Therapeutic Effects of Vitamin D Analogs on Cardiac
Association and the Heart Failure Society of America: Hypertrophy in Spontaneously Hypertensive Rats. Am J
This Statement does not Represent an Update of the Pathol 2010;177:622-31.
2017 ACC/AHA/HFSA Heart Failure Guideline Update. doi: 10.2353/ajpath.2010.091292
Circulation 2019;140:E294-324. [14] Zhang J, Qiu H, Huang J, Sun T, Li G, Liu SQ, et al.
doi: 10.1161/CIR.0000000000000691 Establishment of a Diabetic Myocardial Hypertrophy
[4] Nunes S, Soares E, Pereira F, Reis F. The Role of Model in Mus Musculus Castaneus Mouse. Int J Exp
Inflammation in Diabetic Cardiomyopathy. Int J Pathol 2018;99:295-303.
Interferon Cytokine Mediat Res 2012;4:59. doi: 10.1111/iep.12296
doi: 10.2147/IJICMR.S21679 [15] Yurista SR, Silljé HH, Oberdorf‐Maass SU,
[5] Krenz M, Robbins J. Impact of Beta-Myosin Heavy Schouten EM, Pavez Giani MG, Hillebrands JL, et al.
Chain Expression on Cardiac Function During Stress. Sodium-Glucose Co‐Transporter 2 Inhibition with
J Am Coll Cardiol 2004;44:2390-7. Empagliflozin Improves Cardiac Function in Non‐
doi: 10.1016/j.jacc.2004.09.044 Diabetic Rats with Left Ventricular Dysfunction after
[6] Hutchinson KR, Lord CK, West TA, Stewart JA Jr. Myocardial Infarction. Eur J Heart Fail 2019;21:862-73.
Cardiac Fibroblast-Dependent Extracellular Matrix doi: 10.1002/ejhf.1473
Accumulation Is Associated with Diastolic Stiffness in [16] Yang B, Chen YD, Li M, Zhou FH, Xu Y, Wang GY, et al.
Type 2 Diabetes. PLoS One 2013;8:e72080. Bosentan Attenuates Cardiac Fibrosis in Diabetic Mice
doi: 10.1371/journal.pone.0072080 without Affecting Blood Glucose. J Renin Angiotensin
[7] Tan SM, Zhang Y, Wang B, Tan CY, Zammit SC, Aldosterone Syst 2015;16:NP1-8.
Williams SJ, et al. FT23, an Orally Active Antifibrotic doi: 10.1177/1470320311417274
Compound, Attenuates Structural and Functional [17] Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D,
Abnormalities in an Experimental Model of Diabetic Bauersachs J, Leite-Moreira AF, et al. Towards a Re-
Cardiomyopathy. Clin Exp Pharmacol Physiol Definition of ‘Cardiac Hypertrophy’ Through a Rational
2012;39:650-6. Characterization of Left Ventricular Phenotypes:
doi: 10.1111/j.1440-1681.2012.05726.x A Position Paper of the Working Group ‘Myocardial
[8] Zinman B, Wanner C, Lachin JM, Lachin JM, Fitchett D, Function’ of the ESC. Eur J Heart Fail 2011;13:811-9.
Bluhmki E, et al. Empagliflozin, Cardiovascular doi: 10.1093/eurjhf/hfr071
Outcomes, and Mortality in Type 2 Diabetes. N Engl J [18] Borghetti G, Von Lewinski D, Eaton DM, Sourij H,
Med 2015;373:2117-28. Houser SR, Wallner M. Diabetic Cardiomyopathy:
doi: 10.1056/NEJMoa1504720 Current and Future Therapies. Beyond Glycemic
[9] Lam CS, Chandramouli C, Ahooja V, Verma S. SGLT‐2 Control. Front Physiol 2018;9:1514.
Inhibitors in Heart Failure: Current Management, Unmet doi: 10.3389/fphys.2018.01514
Needs, and Therapeutic Prospects. J Am Heart Assoc [19] Hammoudi N, Jeong D, Singh R, Farhat A, Komajda M,
2019;8:e013389. Mayoux E, et al. Empagliflozin Improves Left Ventricular
doi: 10.1161/JAHA.119.013389 Diastolic Dysfunction in a Genetic Model of Type 2
[10] Zhao H, Zhen Y, Wang Z, Qi L, Li Y, Ren L, et al. Diabetes. Cardiovasc Drugs Ther 2017;31:233-46.
The Relationship between Vitamin D Deficiency doi: 10.1007/s10557-017-6734-1
and Glycated Hemoglobin Levels in Patients with [20] Xue M, Li T, Wang Y, Chang Y, Cheng Y, Lu Y,
Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes et al. Empagliflozin Prevents Cardiomyopathy via
2020;13:3899-907. sGC-cGMP-PKG Pathway in Type 2 Diabetes Mice.
doi: 10.2147/DMSO.S275673 Clin Sci (Lond) 2019;133(15):1705-20.
[11] Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, doi: 10.1042/CS20190585
Kaldrymides P. Vitamin D and Glycemic Control in [21] Habibi J, Aroor AR, Sowers JR, Jia G, Hayden MR,
Diabetes Mellitus Type 2. Ther Adv Endocrinol Metab Garro M, et al. Sodium Glucose Transporter 2 (SGLT2)
2013;4:122-8. Inhibition with Empagliflozin Improves Cardiac
doi: 10.1177/2042018813501189 Diastolic Function in a Female Rodent Model of
[12] Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Diabetes. Cardiovasc Diabetol 2017;16:9.
Zhang Y, et al. Cardiomyocyte-Specific Deletion doi: 10.1186/s12933-016-0489-z
of the Vitamin D Receptor Gene Results in Cardiac [22] Osaka N, Mori Y, Terasaki M, Hiromura M, Saito T,
Hypertrophy. Circulation 2011;124:1838-47. Yashima H, et al. Luseogliflozin Inhibits High Glucose-
doi: 10.1161/CIRCULATIONAHA.111.032680 induced TGF- β 2 Expression in Mouse Cardiomyocytes

DOI: http://doi.org/10.36922/jctr.24.00010